Sheaumann Laser Receives $2.3M Massachusetts Manufacturing Innovation Initiative Award

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command
Sheaumann Laser was recently awarded $2.345 million from the Massachusetts Manufacturing Innovation Initiative (M2I2). Sheaumann Laser specializes in the design and manufacture of semiconductor lasers and modules for industrial, defense, medical, and printing applications. The grant will play a key role in growing Sheaumann’s laser wavelength capability (currently from 780 to 1080 nm) to lasers with wavelengths from 1120 nm to 1875 nm. This growth will nearly double its production capability and add new Marlborough-based jobs.
“The M2I2 program invests in projects that reflect the collaborative spirit of our state and highlight Massachusetts’ nation leading innovation economy,” said Governor Charlie Baker. “These awards support strong business to business partnerships that bring together innovators from across the state, and we are pleased to continue to support their continued growth and development in this sector.” The grant to Sheaumann was uncommonly large for the M2I2 program, recognizing the company’s position as a strong anchor of the Massachusetts economy.
Gary Sousa, Sheaumann’s President, stated at the award ceremony, “While other semiconductor laser foundries have moved overseas to reduce production costs and maintain a competitive advantage in the market, this solution has never been an option for Sheaumann Laser, because we take pride in providing our customers with high-quality laser products that are grown, processed, and packaged in the United States.”
Sheaumann anticipates moving forward quickly with their plans to expand in response to the explosion in growth within the laser diode industry.  “As more industries find new ways to incorporate the capabilities and advantages of laser diodes into their systems, we are seeing increased demand in a variety of new market sectors,” Sousa said.  “We look forward to applying the grant from M2I2 to help us meet those needs.”


Subscribe to Medical Device News Magazine

Related Articles